A San Francisco firefighter who contracted HIV on the job while heroically treating an injured patient is being denied his ...

After months of advocacy from faith and global-health communities, Congress decided in last minute negotiations this week to ...

WHO recommends twice-yearly injectable lenacapavir for HIV prevention, expanding PrEP options for key populations.

A new injectable drug known as lenacapavir could change how millions of people across the world and Africa in particular access HIV protective drugs, which historically have hard to come by. Presented ...

A major HIV drug maker will return $202 million nationwide after a multi-year investigation and settlement. Pharmaceutical ...

The WHO has approved the use of a new drug to prevent HIV. The drug is called Lenacapavir, and what makes it unique is that ...

A new kind of HIV prevention is making it easier for those at risk to stay protected, thanks to a twice-yearly injection now ...